The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty

Journal of Orthopaedic Surgery

Volumn 25, Issue 1, 2017, Pages

  Cankaya, Deniz ^a   Dasar, Uygar ^a   Satilmis, Ahmet Burak ^a   Basaran, Serdar Hakan ^a   Akkaya, Mustafa ^b   Bozkurt, Murat ^b  

^a KARABUK UNIVERSITY   (Turkey)

^b Yildirim Beyazid University   (Turkey)

Author keywords

Blood loss; Drainage; Knee arthroplasty; Oral; Topical; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; TRANYLCYPROMINE; ANTIFIBRINOLYTIC AGENT;

AGE; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; BODY MASS; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENDER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUCTION DRAINAGE; THROMBOEMBOLISM; TOTAL KNEE ARTHROPLASTY; KNEE REPLACEMENT; MIDDLE AGED; OPERATIVE BLOOD LOSS; ORAL DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; PROCEDURES; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85033472146     PISSN: 10225536     EISSN: 23094990     Source Type: Journal    
DOI: 10.1177/2309499016684725     Document Type: Article

References (24)

1. Soni A, Saini R, Gulati A, et al. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 2014; 29: 1525-1527.
2. Alipour M, Tabari M, Keramati M, et al. Effectiveness of oral tranexamic acid administration on blood loss after knee artroplasty: a randomized clinical trial. Transfus Apher Sci 2013; 49: 574-577.
3. Charoencholvanich K and Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011; 469: 2874-2880.
4. Shemshaki H, Nourian SM, Nourian N, et al. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 2015; 135: 573-588.
5. Levine BR, Haughom BD, Belkin MN, et al. Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014; 29(9 Suppl): 186-188.
6. Seo JG, Moon YW, Park SH, et al. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013; 21: 1869-1874.
7. Whiting DR, Gillette BP, Duncan C, et al. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 2014; 472: 66-72.
8. Whiting DR, Duncan CM, Sierra RJ, et al. Tranexamic acid benefits total joint arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplasty 2015; 30: 2098-2101.
9. Alshryda S, Sukeik M, Sarda P, et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014; 96-B: 1005-1015.
10. Gilbody J, Dhotar HS, Perruccio AV, et al. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2014; 29: 681-684.
11. Patel JN, Spanyer JM, Smith LS, et al. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29: 1528-1531.
12. Maniar RN, Kumar G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012; 470: 2605-2612.
13. Lin SY, Chen CH, Fu YC, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty 2015; 30: 776-780.
14. Tuttle JR, Ritterman SA, Cassidy DB, et al. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014; 29: 1512-1515.
15. Zohar E, Ellis M, Ifrach N, et al. The postoperative bloodsparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004; 99: 1679-1683.
16. Irwin A, Khan SK, Jameson SS, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Jt J 2013; 95-B: 1556-1561.
17. Gross JB. Estimating allowable blood loss: corrected for dilution. Anaesthesiology 1983; 58: 277-280.
18. Cankaya D, Ozkurt B, Aydin C, et al. No difference in blood loss between posteriorcruciate-ligament-retaining and posterior-cruciate-ligament-stabilized total knee arthroplasties. Knee Surg Sports Traumatol Arthrosc 2014; 22: 1865-1869.
19. Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014; 349: g4829.
20. Duncan CM, Gillette BP, Jacob AK, et al. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty 2015; 30: 272-276.
21. Eftekharian HR and Rajabzadeh Z. The efficacy of preoperative oral tranexamic acid on intraoperative bleeding during rhinoplasty. J Craniofac Surg 2016; 27: 97-100.
22. Gillette BP, Maradit Kremers H, Duncan CM, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013; 28(8 Suppl): 137-139.
23. Jain NP, Nisthane PP, and Shah NA. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplasty 2016; 31: 542-547.
24. Srivaths LV, Dietrich JE, Yee DL, et al. Oral tranexamic acid versus combined oral contraceptives for adolescent heavy menstrual bleeding: a pilot study. J Pediatr Adolesc Gynecol 2015; 28: 254-257.